Global Ventriculoperitoneal (VP) Shunt Market Research Report 2021-2027

  • receipt Report ID : 219317
  • calendar_today Published On: May, 2021
  • file_copy Pages: 156
  • list Medical Devices

The Ventriculoperitoneal (VP) Shunt market report offers in-dept analysis on the global market size, market share, market growth, sales analysis, regional analysis, market developments, opportunities, and forecasts that will help you in strategizing and expanding your business.

As per the most recent analysis conducted by our research team, the global Ventriculoperitoneal (VP) Shunt market size is projected to reach US$ XX million by 2027 from US $ XX million in 2020 at a CAGR of XX% during 2021-2027.

The report included detailed analysis on the Ventriculoperitoneal (VP) Shunt production capacity, its market share by manufacturers, growth rate, regional production capacity, ex-factory rate, and other important data points. The report also covers Ventriculoperitoneal (VP) Shunt consumption globally as well as thorough bifurcation into regional and country wise consumption.

The research team goes an additional mile to comprehensively cover other important aspects on Ventriculoperitoneal (VP) Shunt market such as the market dynamics, market segmentation, competition, growth prospects, and growth strategies. The buyers of this report will have access to exclusive data that covers market share by applications, manufacturers, regions, and countries. The document also covers market size by type, market competition by manufacturers, sales volume, growth rate, revenue, price and gross margins. Moreover, the authors of this report provide authentic calculations and estimations for global revenue and volume by type segments for Ventriculoperitoneal (VP) Shunt market covering the period 2016-2027.

This report includes the following key manufacturers. We can also add other companies of your choice and customize the report as per your requirements.

  • Sophysa
  • Aesculap
  • B. Braun Melsungen
  • Integra lifesciences
  • Medtronic

Market Segment by Type

  • Fixed Pressure Valves
  • Variable Pressure Valves

Market Segment by Application

  • Hospitals
  • Clinics and Ambulatory Care centers
  • Laboratories
  • Others

Market Segment by Regions and Countries

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, India, Japan, Taiwan, South Korea, Australia, Indonesia, Singapore, Malaysia, Rest of Asia-Pacific)
  • Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
  • Central & South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Turkey, Rest of Middle East & Africa)

The study objectives of this report are:

  • Overview of the Ventriculoperitoneal (VP) Shunt market
  • Analysis on key market segments
  • Key manufacturer analysis based on production, sales, and revenue
  • Ventriculoperitoneal (VP) Shunt market regional and country wise analysis for production and consumption
  • Study the forecast of market in respect to manufacturers, segments, and regions
  • Identify significant trends and factors driving the market growth
  • Analyse the available opportunities in the market by tracing high growth segments
  • Analyse competitive developments like acquisitions, expansions, product launches, agreements, etc.
  • Study the growth strategies of key manufacturers
  • SWOT analysis

In this study, the years considered to estimate the market size of Ventriculoperitoneal (VP) Shunt are as follows:

History Year: 2016-2020

Base Year: 2020

Estimated Year: 2021

Forecast Year 2021 to 2027

Available Customizations

Market Research Place offers customizations according to the client's specific needs. The report can be customized on the basis of manufacturers, regions, applications, etc. Contact us to know more about the customization options.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Report Overview

1.1 Research Scope

1.2 Market Segment by Type

1.2.1 Global Ventriculoperitoneal (VP) Shunt Market Size Growth Rate by Type

1.2.2 Fixed Pressure Valves

1.2.3 Variable Pressure Valves

1.3 Market Segment by Application

1.3.1 Global Ventriculoperitoneal (VP) Shunt Market Share by Application (2016 VS 2021 VS 2027)

1.3.2 Hospitals

1.3.3 Clinics and Ambulatory Care centers

1.3.4 Laboratories

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global Ventriculoperitoneal (VP) Shunt Market Size (2016-2027)

2.1.1 Global Ventriculoperitoneal (VP) Shunt Revenue (2016-2027)

2.1.2 Global Ventriculoperitoneal (VP) Shunt Sales (2016-2027)

2.2 Global Ventriculoperitoneal (VP) Shunt Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027

2.2.1 Global Ventriculoperitoneal (VP) Shunt Sales by Regions (2016-2021)

2.2.2 Global Ventriculoperitoneal (VP) Shunt Revenue by Regions (2016-2021)

2.3 Global Ventriculoperitoneal (VP) Shunt Market Size Forecast by Region

2.3.1 Global Ventriculoperitoneal (VP) Shunt Sales Forecast by Region (2022-2027)

2.3.2 Global Ventriculoperitoneal (VP) Shunt Revenue Forecast by Region (2022-2027)

2.4 Global Top Ventriculoperitoneal (VP) Shunt Regions (Countries) Ranking by Market Size

2.5 Ventriculoperitoneal (VP) Shunt Industry Trends

2.5.1 Ventriculoperitoneal (VP) Shunt Market Trends

2.5.2 Ventriculoperitoneal (VP) Shunt Market Drivers

2.5.3 Ventriculoperitoneal (VP) Shunt Market Challenges

2.5.4 Ventriculoperitoneal (VP) Shunt Market Restraints

3 Competitive Landscape by Manufacturers

3.1 Global Top Ventriculoperitoneal (VP) Shunt Manufacturers by Sales (2016-2021)

3.1.1 Global Ventriculoperitoneal (VP) Shunt Sales by Manufacturers (2016-2021)

3.1.2 Global Ventriculoperitoneal (VP) Shunt Sales Market Share by Manufacturers (2016-2021)

3.1.3 Global 5 and 10 Largest Manufacturers by Ventriculoperitoneal (VP) Shunt Sales in 2020

3.2 Global Top Manufacturers Ventriculoperitoneal (VP) Shunt by Revenue

3.2.1 Global Ventriculoperitoneal (VP) Shunt Revenue by Manufacturers (2016-2021)

3.2.2 Top Ventriculoperitoneal (VP) Shunt Manufacturers Covered: Ranking by Revenue

3.2.3 Global Ventriculoperitoneal (VP) Shunt Revenue Share by Manufacturers (2016-2021)

3.2.4 Global Ventriculoperitoneal (VP) Shunt Market Concentration Ratio (CR5 and HHI)

3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ventriculoperitoneal (VP) Shunt as of 2020)

3.4 Global Ventriculoperitoneal (VP) Shunt Average Selling Price (ASP) by Manufacturers

3.5 Key Manufacturers Ventriculoperitoneal (VP) Shunt Plants/Factories Distribution and Area Served

3.6 Date of Key Manufacturers Enter into Ventriculoperitoneal (VP) Shunt Market

3.7 Key Manufacturers Ventriculoperitoneal (VP) Shunt Product Offered

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Ventriculoperitoneal (VP) Shunt Market Size by Type

4.1 Global Ventriculoperitoneal (VP) Shunt Historic Market Review by Type (2016-2021)

4.1.1 Global Ventriculoperitoneal (VP) Shunt Sales Market Share by Type (2016-2021)

4.1.2 Global Ventriculoperitoneal (VP) Shunt Revenue Market Share by Type (2016-2021)

4.1.3 Ventriculoperitoneal (VP) Shunt Price by Type (2016-2021)

4.2 Global Ventriculoperitoneal (VP) Shunt Market Estimates and Forecasts by Type (2022-2027)

4.2.1 Global Ventriculoperitoneal (VP) Shunt Sales Forecast by Type (2022-2027)

4.2.2 Global Ventriculoperitoneal (VP) Shunt Revenue Forecast by Type (2022-2027)

4.2.3 Ventriculoperitoneal (VP) Shunt Price Forecast by Type (2022-2027)

5 Global Ventriculoperitoneal (VP) Shunt Market Size by Application

5.1 Global Ventriculoperitoneal (VP) Shunt Historic Market Review by Application (2016-2021)

5.1.1 Global Ventriculoperitoneal (VP) Shunt Sales Market Share by Application (2016-2021)

5.1.2 Global Ventriculoperitoneal (VP) Shunt Revenue Market Share by Application (2016-2021)

5.1.3 Ventriculoperitoneal (VP) Shunt Price by Application (2016-2021)

5.2 Global Ventriculoperitoneal (VP) Shunt Market Estimates and Forecasts by Application (2022-2027)

5.2.1 Global Ventriculoperitoneal (VP) Shunt Sales Forecast by Application (2022-2027)

5.2.2 Global Ventriculoperitoneal (VP) Shunt Revenue Forecast by Application (2022-2027)

5.2.3 Ventriculoperitoneal (VP) Shunt Price Forecast by Application (2022-2027)

6 North America

6.1 North America Ventriculoperitoneal (VP) Shunt Sales Breakdown by Company

6.1.1 North America Ventriculoperitoneal (VP) Shunt Sales by Company (2016-2027)

6.1.2 North America Ventriculoperitoneal (VP) Shunt Revenue by Company (2016-2027)

6.2 North America Ventriculoperitoneal (VP) Shunt Market Size by Type (2016-2027)

6.2.1 North America Ventriculoperitoneal (VP) Shunt Sales by Type (2016-2027)

6.2.2 North America Ventriculoperitoneal (VP) Shunt Revenue by Type (2016-2027)

6.3 North America Ventriculoperitoneal (VP) Shunt Market Size by Application (2016-2027)

6.3.1 North America Ventriculoperitoneal (VP) Shunt Sales by Application (2016-2027)

6.3.2 North America Ventriculoperitoneal (VP) Shunt Revenue by Application (2016-2027)

6.4 North America Ventriculoperitoneal (VP) Shunt Market Size by Country

6.4.1 North America Ventriculoperitoneal (VP) Shunt Sales by Country (2016-2027)

6.4.2 North America Ventriculoperitoneal (VP) Shunt Revenue by Country (2016-2027)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Ventriculoperitoneal (VP) Shunt Sales Breakdown by Company

7.1.1 Europe Ventriculoperitoneal (VP) Shunt Sales by Company (2016-2027)

7.1.2 Europe Ventriculoperitoneal (VP) Shunt Revenue by Company (2016-2027)

7.2 Europe Ventriculoperitoneal (VP) Shunt Market Size by Type (2016-2027)

7.2.1 Europe Ventriculoperitoneal (VP) Shunt Sales by Type (2016-2027)

7.2.2 Europe Ventriculoperitoneal (VP) Shunt Revenue by Type (2016-2027)

7.3 Europe Ventriculoperitoneal (VP) Shunt Market Size by Application (2016-2027)

7.3.1 Europe Ventriculoperitoneal (VP) Shunt Sales by Application (2016-2027)

7.3.2 Europe Ventriculoperitoneal (VP) Shunt Revenue by Application (2016-2027)

7.4 Europe Ventriculoperitoneal (VP) Shunt Market Size by Country

7.4.1 Europe Ventriculoperitoneal (VP) Shunt Sales by Country (2016-2027)

7.4.2 Europe Ventriculoperitoneal (VP) Shunt Revenue by Country (2016-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

8 Asia Pacific

8.1 Asia Pacific Ventriculoperitoneal (VP) Shunt Sales Breakdown by Company

8.1.1 Asia Pacific Ventriculoperitoneal (VP) Shunt Sales by Company (2016-2027)

8.1.2 Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue by Company (2016-2027)

8.2 Asia Pacific Ventriculoperitoneal (VP) Shunt Market Size by Type (2016-2027)

8.2.1 Asia Pacific Ventriculoperitoneal (VP) Shunt Sales by Type (2016-2027)

8.2.2 Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue by Type (2016-2027)

8.3 Asia Pacific Ventriculoperitoneal (VP) Shunt Market Size by Application (2016-2027)

8.3.1 Asia Pacific Ventriculoperitoneal (VP) Shunt Sales by Application (2016-2027)

8.3.2 Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue by Application (2016-2027)

8.4 Asia Pacific Ventriculoperitoneal (VP) Shunt Market Size by Regions

8.4.1 Asia Pacific Ventriculoperitoneal (VP) Shunt Sales by Regions

8.4.2 Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue by Regions

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 India

8.4.7 Australia

8.4.8 Taiwan

8.4.9 Indonesia

8.4.10 Thailand

8.4.11 Malaysia

8.4.12 Philippines

8.4.13 Vietnam

9 Latin America

9.1 Latin America Ventriculoperitoneal (VP) Shunt Sales Breakdown by Company

9.1.1 Latin America Ventriculoperitoneal (VP) Shunt Sales by Company (2016-2027)

9.1.2 Latin America Ventriculoperitoneal (VP) Shunt Revenue by Company (2016-2027)

9.2 Latin America Ventriculoperitoneal (VP) Shunt Market Size by Type (2016-2027)

9.2.1 Latin America Ventriculoperitoneal (VP) Shunt Sales by Type (2016-2027)

9.2.2 Latin America Ventriculoperitoneal (VP) Shunt Revenue by Type (2016-2027)

9.3 Latin America Ventriculoperitoneal (VP) Shunt Market Size by Application (2016-2027)

9.3.1 Latin America Ventriculoperitoneal (VP) Shunt Sales by Application (2016-2027)

9.3.2 Latin America Ventriculoperitoneal (VP) Shunt Revenue by Application (2016-2027)

9.4 Latin America Ventriculoperitoneal (VP) Shunt Market Size by Country

9.4.1 Latin America Ventriculoperitoneal (VP) Shunt Sales by Country (2016-2027)

9.4.2 Latin America Ventriculoperitoneal (VP) Shunt Revenue by Country (2016-2027)

9.4.3 Mexico

9.4.4 Brazil

9.4.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales Breakdown by Company

10.1.1 Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales by Company (2016-2027)

10.1.2 Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue by Company (2016-2027)

10.2 Middle East and Africa Ventriculoperitoneal (VP) Shunt Market Size by Type (2016-2027)

10.2.1 Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales by Type (2016-2027)

10.2.2 Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue by Type (2016-2027)

10.3 Middle East and Africa Ventriculoperitoneal (VP) Shunt Market Size by Application (2016-2027)

10.3.1 Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales by Application (2016-2027)

10.3.2 Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue by Application (2016-2027)

10.4 Middle East and Africa Ventriculoperitoneal (VP) Shunt Market Size by Country

10.4.1 Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales by Country (2016-2027)

10.4.2 Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue by Country (2016-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 U.A.E

11 Company Profiles

11.1 Sophysa

11.1.1 Sophysa Corporation Information

11.1.2 Sophysa Overview

11.1.3 Sophysa Ventriculoperitoneal (VP) Shunt Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.1.4 Sophysa Ventriculoperitoneal (VP) Shunt Products and Services

11.1.5 Sophysa Ventriculoperitoneal (VP) Shunt SWOT Analysis

11.1.6 Sophysa Recent Developments

11.2 Aesculap

11.2.1 Aesculap Corporation Information

11.2.2 Aesculap Overview

11.2.3 Aesculap Ventriculoperitoneal (VP) Shunt Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.2.4 Aesculap Ventriculoperitoneal (VP) Shunt Products and Services

11.2.5 Aesculap Ventriculoperitoneal (VP) Shunt SWOT Analysis

11.2.6 Aesculap Recent Developments

11.3 B. Braun Melsungen

11.3.1 B. Braun Melsungen Corporation Information

11.3.2 B. Braun Melsungen Overview

11.3.3 B. Braun Melsungen Ventriculoperitoneal (VP) Shunt Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.3.4 B. Braun Melsungen Ventriculoperitoneal (VP) Shunt Products and Services

11.3.5 B. Braun Melsungen Ventriculoperitoneal (VP) Shunt SWOT Analysis

11.3.6 B. Braun Melsungen Recent Developments

11.4 Integra lifesciences

11.4.1 Integra lifesciences Corporation Information

11.4.2 Integra lifesciences Overview

11.4.3 Integra lifesciences Ventriculoperitoneal (VP) Shunt Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.4.4 Integra lifesciences Ventriculoperitoneal (VP) Shunt Products and Services

11.4.5 Integra lifesciences Ventriculoperitoneal (VP) Shunt SWOT Analysis

11.4.6 Integra lifesciences Recent Developments

11.5 Medtronic

11.5.1 Medtronic Corporation Information

11.5.2 Medtronic Overview

11.5.3 Medtronic Ventriculoperitoneal (VP) Shunt Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.5.4 Medtronic Ventriculoperitoneal (VP) Shunt Products and Services

11.5.5 Medtronic Ventriculoperitoneal (VP) Shunt SWOT Analysis

11.5.6 Medtronic Recent Developments

12 Value Chain and Sales Channels Analysis

12.1 Ventriculoperitoneal (VP) Shunt Value Chain Analysis

12.2 Ventriculoperitoneal (VP) Shunt Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Ventriculoperitoneal (VP) Shunt Production Mode & Process

12.4 Ventriculoperitoneal (VP) Shunt Sales and Marketing

12.4.1 Ventriculoperitoneal (VP) Shunt Sales Channels

12.4.2 Ventriculoperitoneal (VP) Shunt Distributors

12.5 Ventriculoperitoneal (VP) Shunt Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

List of Tables

Table 1. Global Ventriculoperitoneal (VP) Shunt Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)

Table 2. Major Manufacturers of Fixed Pressure Valves

Table 3. Major Manufacturers of Variable Pressure Valves

Table 4. Global Ventriculoperitoneal (VP) Shunt Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)

Table 5. Global Market Ventriculoperitoneal (VP) Shunt Market Size (US$ Million) by Region: 2016 VS 2021 VS 2027

Table 6. Global Ventriculoperitoneal (VP) Shunt Sales by Region (2016-2021) & (K Units)

Table 7. Global Ventriculoperitoneal (VP) Shunt Sales Market Share by Region (2016-2021)

Table 8. Global Ventriculoperitoneal (VP) Shunt Revenue by Region (2016-2021) & (US$ Million)

Table 9. Global Ventriculoperitoneal (VP) Shunt Revenue Market Share by Region (2016-2021)

Table 10. Global Ventriculoperitoneal (VP) Shunt Sales Forecast by Region (2022-2027) & (K Units)

Table 11. Global Ventriculoperitoneal (VP) Shunt Sales Market Share Forecast by Region (2022-2027)

Table 12. Global Ventriculoperitoneal (VP) Shunt Revenue Forecast by Region (2022-2027) & (US$ Million)

Table 13. Global Ventriculoperitoneal (VP) Shunt Revenue Market Share Forecast by Region (2022-2027)

Table 14. Top Ventriculoperitoneal (VP) Shunt Regions (Countries) Ranking by Market Size (US$ Million) in 2020

Table 15. Ventriculoperitoneal (VP) Shunt Market Trends

Table 16. Ventriculoperitoneal (VP) Shunt Market Drivers

Table 17. Ventriculoperitoneal (VP) Shunt Market Challenges

Table 18. Ventriculoperitoneal (VP) Shunt Market Restraints

Table 19. Global Ventriculoperitoneal (VP) Shunt Sales by Manufacturers (2016-2021) & (K Units)

Table 20. Global Ventriculoperitoneal (VP) Shunt Sales Share by Manufacturers (2016-2021)

Table 21. Global Ventriculoperitoneal (VP) Shunt Revenue by Manufacturers (2016-2021) & (US$ Million)

Table 22. Ranking of Global Top Ventriculoperitoneal (VP) Shunt Manufacturers by Revenue (US$ Million) in 2020

Table 23. Ventriculoperitoneal (VP) Shunt Revenue Share by Manufacturers (2016-2021)

Table 24. Global Ventriculoperitoneal (VP) Shunt Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ventriculoperitoneal (VP) Shunt as of 2020)

Table 26. Key Manufacturers Ventriculoperitoneal (VP) Shunt Average Selling Price (ASP) & (2016-2021) & (USD/Unit)

Table 27. Key Manufacturers Ventriculoperitoneal (VP) Shunt Plants/Factories Distribution

Table 28. Key Manufacturers Ventriculoperitoneal (VP) Shunt Area Served

Table 29. Date of Key Manufacturers Enter into Ventriculoperitoneal (VP) Shunt Market

Table 30. Key Manufacturers Ventriculoperitoneal (VP) Shunt Product Type

Table 31. Mergers & Acquisitions, Expansion Plans

Table 32. Global Ventriculoperitoneal (VP) Shunt Sales (K Units) by Type (2016-2021)

Table 33. Global Ventriculoperitoneal (VP) Shunt Sales Share by Type (2016-2021)

Table 34. Global Ventriculoperitoneal (VP) Shunt Revenue (US$ Million) Market Share by Type (2016-2021)

Table 35. Global Ventriculoperitoneal (VP) Shunt Price (K Units) by Type (2016-2021)

Table 36. Global Ventriculoperitoneal (VP) Shunt Sales (K Units) by Type (2022-2027)

Table 37. Global Ventriculoperitoneal (VP) Shunt Sales Share by Type (2022-2027)

Table 38. Global Ventriculoperitoneal (VP) Shunt Revenue (US$ Million) Market Share by Type (2022-2027)

Table 39. Global Ventriculoperitoneal (VP) Shunt Revenue Share by Type (2022-2027)

Table 40. Global Ventriculoperitoneal (VP) Shunt Price (K Units) by Type (2022-2027)

Table 41. Global Ventriculoperitoneal (VP) Shunt Sales (K Units) by Application (2016-2021)

Table 42. Global Ventriculoperitoneal (VP) Shunt Sales Share by Application (2016-2021)

Table 43. Global Ventriculoperitoneal (VP) Shunt Revenue (US$ Million) Market Share by Application (2016-2021)

Table 44. Global Ventriculoperitoneal (VP) Shunt Price (K Units) by Application (2016-2021)

Table 45. Global Ventriculoperitoneal (VP) Shunt Sales (K Units) by Application (2022-2027)

Table 46. Global Ventriculoperitoneal (VP) Shunt Sales Share by Application (2022-2027)

Table 47. Global Ventriculoperitoneal (VP) Shunt Revenue (US$ Million) Market Share by Application (2022-2027)

Table 48. Global Ventriculoperitoneal (VP) Shunt Revenue Share by Application (2022-2027)

Table 49. Global Ventriculoperitoneal (VP) Shunt Price (K Units) by Application (2022-2027)

Table 50. North America Ventriculoperitoneal (VP) Shunt Sales by Company (2016-2021) & (K Units)

Table 51. North America Ventriculoperitoneal (VP) Shunt Sales Market Share by Company (2016-2021)

Table 52. North America Ventriculoperitoneal (VP) Shunt Revenue by Company (2016-2021) & (US$ Million)

Table 53. North America Ventriculoperitoneal (VP) Shunt Revenue Market Share by Company (2016-2021)

Table 54. North America Ventriculoperitoneal (VP) Shunt Sales by Application (2016-2021) & (K Units)

Table 55. North America Ventriculoperitoneal (VP) Shunt Sales by Application (2022-2027) & (K Units)

Table 56. North America Ventriculoperitoneal (VP) Shunt Revenue by Application (2016-2021) & (US$ Million)

Table 57. North America Ventriculoperitoneal (VP) Shunt Revenue by Application (2022-2027) & (US$ Million)

Table 58. North America Ventriculoperitoneal (VP) Shunt Sales by Application (2016-2021) & (K Units)

Table 59. North America Ventriculoperitoneal (VP) Shunt Sales by Application (2022-2027) & (K Units)

Table 60. North America Ventriculoperitoneal (VP) Shunt Revenue by Application (2016-2021) & (US$ Million)

Table 61. North America Ventriculoperitoneal (VP) Shunt Revenue by Application (2022-2027) & (US$ Million)

Table 62. North America Ventriculoperitoneal (VP) Shunt Sales by Country (2016-2021) & (K Units)

Table 63. North America Ventriculoperitoneal (VP) Shunt Sales by Country (2022-2027) & (K Units)

Table 64. North America Ventriculoperitoneal (VP) Shunt Revenue by Country (2016-2021) & (US$ Million)

Table 65. North America Ventriculoperitoneal (VP) Shunt Revenue by Country (2022-2027) & (US$ Million)

Table 66. Europe Ventriculoperitoneal (VP) Shunt Sales by Company (2016-2021) & (K Units)

Table 67. Europe Ventriculoperitoneal (VP) Shunt Sales Market Share by Company (2016-2021)

Table 68. Europe Ventriculoperitoneal (VP) Shunt Revenue by Company (2016-2021) & (US$ Million)

Table 69. Europe Ventriculoperitoneal (VP) Shunt Revenue Market Share by Company (2016-2021)

Table 70. Europe Ventriculoperitoneal (VP) Shunt Sales by Application (2016-2021) & (K Units)

Table 71. Europe Ventriculoperitoneal (VP) Shunt Sales by Application (2022-2027) & (K Units)

Table 72. Europe Ventriculoperitoneal (VP) Shunt Revenue by Application (2016-2021) & (US$ Million)

Table 73. Europe Ventriculoperitoneal (VP) Shunt Revenue by Application (2022-2027) & (US$ Million)

Table 74. Europe Ventriculoperitoneal (VP) Shunt Sales by Application (2016-2021) & (K Units)

Table 75. Europe Ventriculoperitoneal (VP) Shunt Sales by Application (2022-2027) & (K Units)

Table 76. Europe Ventriculoperitoneal (VP) Shunt Revenue by Application (2016-2021) & (US$ Million)

Table 77. Europe Ventriculoperitoneal (VP) Shunt Revenue by Application (2022-2027) & (US$ Million)

Table 78. Europe Ventriculoperitoneal (VP) Shunt Sales by Country (2016-2021) & (K Units)

Table 79. Europe Ventriculoperitoneal (VP) Shunt Sales by Country (2022-2027) & (K Units)

Table 80. Europe Ventriculoperitoneal (VP) Shunt Revenue by Country (2016-2021) & (US$ Million)

Table 81. Europe Ventriculoperitoneal (VP) Shunt Revenue by Country (2022-2027) & (US$ Million)

Table 82. Asia Pacific Ventriculoperitoneal (VP) Shunt Sales by Company (2016-2021) & (K Units)

Table 83. Asia Pacific Ventriculoperitoneal (VP) Shunt Sales Market Share by Company (2016-2021)

Table 84. Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue by Company (2016-2021) & (US$ Million)

Table 85. Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue Market Share by Company (2016-2021)

Table 86. Asia Pacific Ventriculoperitoneal (VP) Shunt Sales by Application (2016-2021) & (K Units)

Table 87. Asia Pacific Ventriculoperitoneal (VP) Shunt Sales by Application (2022-2027) & (K Units)

Table 88. Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue by Application (2016-2021) & (US$ Million)

Table 89. Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue by Application (2022-2027) & (US$ Million)

Table 90. Asia Pacific Ventriculoperitoneal (VP) Shunt Sales by Application (2016-2021) & (K Units)

Table 91. Asia Pacific Ventriculoperitoneal (VP) Shunt Sales by Application (2022-2027) & (K Units)

Table 92. Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue by Application (2016-2021) & (US$ Million)

Table 93. Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue by Application (2022-2027) & (US$ Million)

Table 94. Asia Pacific Ventriculoperitoneal (VP) Shunt Sales by Region (2016-2021) & (K Units)

Table 95. Asia Pacific Ventriculoperitoneal (VP) Shunt Sales by Region (2022-2027) & (K Units)

Table 96. Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue by Region (2016-2021) & (US$ Million)

Table 97. Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue by Region (2022-2027) & (US$ Million)

Table 98. Latin America Ventriculoperitoneal (VP) Shunt Sales by Company (2016-2021) & (K Units)

Table 99. Latin America Ventriculoperitoneal (VP) Shunt Sales Market Share by Company (2016-2021)

Table 100. Latin America Ventriculoperitoneal (VP) Shunt Revenue by Company (2016-2021) & (US$ Million)

Table 101. Latin America Ventriculoperitoneal (VP) Shunt Revenue Market Share by Company (2016-2021)

Table 102. Latin America Ventriculoperitoneal (VP) Shunt Sales by Application (2016-2021) & (K Units)

Table 103. Latin America Ventriculoperitoneal (VP) Shunt Sales by Application (2022-2027) & (K Units)

Table 104. Latin America Ventriculoperitoneal (VP) Shunt Revenue by Application (2016-2021) & (US$ Million)

Table 105. Latin America Ventriculoperitoneal (VP) Shunt Revenue by Application (2022-2027) & (US$ Million)

Table 106. Latin America Ventriculoperitoneal (VP) Shunt Sales by Application (2016-2021) & (K Units)

Table 107. Latin America Ventriculoperitoneal (VP) Shunt Sales by Application (2022-2027) & (K Units)

Table 108. Latin America Ventriculoperitoneal (VP) Shunt Revenue by Application (2016-2021) & (US$ Million)

Table 109. Latin America Ventriculoperitoneal (VP) Shunt Revenue by Application (2022-2027) & (US$ Million)

Table 110. Latin America Ventriculoperitoneal (VP) Shunt Sales by Country (2016-2021) & (K Units)

Table 111. Latin America Ventriculoperitoneal (VP) Shunt Sales by Country (2022-2027) & (K Units)

Table 112. Latin America Ventriculoperitoneal (VP) Shunt Revenue by Country (2016-2021) & (US$ Million)

Table 113. Latin America Ventriculoperitoneal (VP) Shunt Revenue by Country (2022-2027) & (US$ Million)

Table 114. Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales by Company (2016-2021) & (K Units)

Table 115. Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales Market Share by Company (2016-2021)

Table 116. Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue by Company (2016-2021) & (US$ Million)

Table 117. Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue Market Share by Company (2016-2021)

Table 118. Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales by Application (2016-2021) & (K Units)

Table 119. Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales by Application (2022-2027) & (K Units)

Table 120. Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue by Application (2016-2021) & (US$ Million)

Table 121. Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue by Application (2022-2027) & (US$ Million)

Table 122. Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales by Application (2016-2021) & (K Units)

Table 123. Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales by Application (2022-2027) & (K Units)

Table 124. Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue by Application (2016-2021) & (US$ Million)

Table 125. Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue by Application (2022-2027) & (US$ Million)

Table 126. Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales by Country (2016-2021) & (K Units)

Table 127. Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales by Country (2022-2027) & (K Units)

Table 128. Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue by Country (2016-2021) & (US$ Million)

Table 129. Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue by Country (2022-2027) & (US$ Million)

Table 130. Sophysa Corporation Information

Table 131. Sophysa Description and Overview

Table 132. Sophysa Ventriculoperitoneal (VP) Shunt Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 133. Sophysa Ventriculoperitoneal (VP) Shunt Product and Services

Table 134. Sophysa Ventriculoperitoneal (VP) Shunt SWOT Analysis

Table 135. Sophysa Recent Developments

Table 136. Aesculap Corporation Information

Table 137. Aesculap Description and Overview

Table 138. Aesculap Ventriculoperitoneal (VP) Shunt Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 139. Aesculap Ventriculoperitoneal (VP) Shunt Product and Services

Table 140. Aesculap Ventriculoperitoneal (VP) Shunt SWOT Analysis

Table 141. Aesculap Recent Developments

Table 142. B. Braun Melsungen Corporation Information

Table 143. B. Braun Melsungen Description and Overview

Table 144. B. Braun Melsungen Ventriculoperitoneal (VP) Shunt Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 145. B. Braun Melsungen Ventriculoperitoneal (VP) Shunt Product and Services

Table 146. B. Braun Melsungen Ventriculoperitoneal (VP) Shunt SWOT Analysis

Table 147. B. Braun Melsungen Recent Developments

Table 148. Integra lifesciences Corporation Information

Table 149. Integra lifesciences Description and Overview

Table 150. Integra lifesciences Ventriculoperitoneal (VP) Shunt Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 151. Integra lifesciences Ventriculoperitoneal (VP) Shunt Product and Services

Table 152. Integra lifesciences Ventriculoperitoneal (VP) Shunt SWOT Analysis

Table 153. Integra lifesciences Recent Developments

Table 154. Medtronic Corporation Information

Table 155. Medtronic Description and Overview

Table 156. Medtronic Ventriculoperitoneal (VP) Shunt Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 157. Medtronic Ventriculoperitoneal (VP) Shunt Product and Services

Table 158. Medtronic Ventriculoperitoneal (VP) Shunt SWOT Analysis

Table 159. Medtronic Recent Developments

Table 160. Key Raw Materials Lists

Table 161. Raw Materials Key Suppliers Lists

Table 162. Ventriculoperitoneal (VP) Shunt Distributors List

Table 163. Ventriculoperitoneal (VP) Shunt Customers List

Table 164. Research Programs/Design for This Report

Table 165. Key Data Information from Secondary Sources

Table 166. Key Data Information from Primary Sources

List of Figures

Figure 1. Ventriculoperitoneal (VP) Shunt Product Picture

Figure 2. Global Ventriculoperitoneal (VP) Shunt Sales Market Share by Type in 2020 & 2027

Figure 3. Fixed Pressure Valves Picture

Figure 4. Variable Pressure Valves Picture

Figure 5. Global Ventriculoperitoneal (VP) Shunt Sales Market Share by Application in 2020 & 2027

Figure 6. Hospitals Use Case

Figure 7. Clinics and Ambulatory Care centers Use Case

Figure 8. Laboratories Use Case

Figure 9. Others Use Case

Figure 10. Ventriculoperitoneal (VP) Shunt Report Years Considered

Figure 11. Global Ventriculoperitoneal (VP) Shunt Revenue, (US$ Million), 2016 VS 2021 VS 2027

Figure 12. Global Ventriculoperitoneal (VP) Shunt Market Size 2016-2027 (US$ Million)

Figure 13. Global Ventriculoperitoneal (VP) Shunt Sales (2016-2021) & (K Units)

Figure 14. Global Ventriculoperitoneal (VP) Shunt Market Size Market Share by Region: 2020 VS 2027

Figure 15. Global Ventriculoperitoneal (VP) Shunt Sales Market Share by Region (2016-2021)

Figure 16. Global Ventriculoperitoneal (VP) Shunt Sales Market Share by Region in 2020

Figure 17. Global Ventriculoperitoneal (VP) Shunt Revenue Market Share by Region in 2016 VS 2020

Figure 18. Global Ventriculoperitoneal (VP) Shunt Sales Share by Manufacturers In 2020

Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Ventriculoperitoneal (VP) Shunt Sales in 2020

Figure 20. Ventriculoperitoneal (VP) Shunt Revenue Share by Manufacturers In 2020

Figure 21. Ventriculoperitoneal (VP) Shunt Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020

Figure 22. Global Ventriculoperitoneal (VP) Shunt Revenue Share by Type (2016-2021)

Figure 23. Global Ventriculoperitoneal (VP) Shunt Revenue Growth Rate by Type in 2016 & 2020

Figure 24. Global Ventriculoperitoneal (VP) Shunt Revenue Share by Application (2016-2021)

Figure 25. Global Ventriculoperitoneal (VP) Shunt Revenue Growth Rate by Application in 2016 & 2020

Figure 26. North America Ventriculoperitoneal (VP) Shunt Sales Market Share by Type (2016-2027)

Figure 27. North America Ventriculoperitoneal (VP) Shunt Revenue Market Share by Type (2016-2027)

Figure 28. North America Ventriculoperitoneal (VP) Shunt Sales Market Share by Application (2016-2027)

Figure 29. North America Ventriculoperitoneal (VP) Shunt Revenue Market Share by Application (2016-2027)

Figure 30. North America Ventriculoperitoneal (VP) Shunt Sales Share by Country (2016-2027)

Figure 31. North America Ventriculoperitoneal (VP) Shunt Revenue Share by Country (2016-2027)

Figure 32. U.S. Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 33. Canada Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 34. Europe Ventriculoperitoneal (VP) Shunt Sales Market Share by Type (2016-2027)

Figure 35. Europe Ventriculoperitoneal (VP) Shunt Revenue Market Share by Type (2016-2027)

Figure 36. Europe Ventriculoperitoneal (VP) Shunt Sales Market Share by Application (2016-2027)

Figure 37. Europe Ventriculoperitoneal (VP) Shunt Revenue Market Share by Application (2016-2027)

Figure 38. Europe Ventriculoperitoneal (VP) Shunt Sales Share by Country (2016-2027)

Figure 39. Europe Ventriculoperitoneal (VP) Shunt Revenue Share by Country (2016-2027)

Figure 40. Germany Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 41. France Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 42. U.K. Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 43. Italy Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 44. Russia Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 45. Asia Pacific Ventriculoperitoneal (VP) Shunt Sales Market Share by Type (2016-2027)

Figure 46. Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue Market Share by Type (2016-2027)

Figure 47. Asia Pacific Ventriculoperitoneal (VP) Shunt Sales Market Share by Application (2016-2027)

Figure 48. Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue Market Share by Application (2016-2027)

Figure 49. Asia Pacific Ventriculoperitoneal (VP) Shunt Sales Share by Region (2016-2027)

Figure 50. Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue Share by Region (2016-2027)

Figure 51. China Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 52. Japan Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 53. South Korea Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 54. India Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 55. Australia Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 56. Taiwan Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 57. Indonesia Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 58. Thailand Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 59. Malaysia Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 60. Philippines Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 61. Vietnam Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 62. Latin America Ventriculoperitoneal (VP) Shunt Sales Market Share by Type (2016-2027)

Figure 63. Latin America Ventriculoperitoneal (VP) Shunt Revenue Market Share by Type (2016-2027)

Figure 64. Latin America Ventriculoperitoneal (VP) Shunt Sales Market Share by Application (2016-2027)

Figure 65. Latin America Ventriculoperitoneal (VP) Shunt Revenue Market Share by Application (2016-2027)

Figure 66. Latin America Ventriculoperitoneal (VP) Shunt Sales Share by Country (2016-2027)

Figure 67. Latin America Ventriculoperitoneal (VP) Shunt Revenue Share by Country (2016-2027)

Figure 68. Mexico Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 69. Brazil Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 70. Argentina Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 71. Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales Market Share by Type (2016-2027)

Figure 72. Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue Market Share by Type (2016-2027)

Figure 73. Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales Market Share by Application (2016-2027)

Figure 74. Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue Market Share by Application (2016-2027)

Figure 75. Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales Share by Country (2016-2027)

Figure 76. Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue Share by Country (2016-2027)

Figure 77. Turkey Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 78. Saudi Arabia Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 79. U.A.E Ventriculoperitoneal (VP) Shunt Revenue (2016-2027) & (US$ Million)

Figure 80. Ventriculoperitoneal (VP) Shunt Value Chain

Figure 81. Ventriculoperitoneal (VP) Shunt Production Process

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

Please fill the form below, to recieve the report sample


+1